Cancer Biomarkers Market Size, Share, Growth, Trends, Production, Revenue, Sales and Forecast 2020 to 2027

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Cancer Biomarkers Products Market Overview
4.1 Introduction (Product Definition)
4.2 Industry Evolution/Development
4.3 Key Market Indicators
4.4 Market Dynamics
4.4.1 Drivers
4.4.2 Restraints
4.4.3 Opportunity
4.5 Global Cancer Biomarkers Market Analysis and Forecasts, 2020-2027
4.6 Cancer Biomarkers Market - Global Supply Demand Scenario
4.7 Porter’s Five Force Analysis
4.8 Market Outlook
4.9 Cancer Epidemiology, by region

5. Global Cancer Biomarkers Market Analysis and Forecast by Test Type
5.1 Key Findings
5.2 Introduction
5.3 Market Size (US$ Mn) Forecast, By Test Type
5.3.1 PSA Tests
5.3.2 CTC Tests
5.3.3 AFP Tests
5.3.4 CA Tests
5.3.5 HER2 Tests
5.3.6 BRCA Tests
5.3.7 ALK Tests
5.3.8 CEA Tests
5.3.9 EGFR Mutation Tests
5.3.10 KRAS Mutation Tests
5.3.11 Others
5.4 Market Attractiveness, By Test Type
5.5 Key Trends

6. Global Cancer Biomarkers Market Analysis and Forecast by Disease Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Size (US$ Mn) Forecast, By Disease Indication
6.3.1 Breast Cancer
6.3.2 Lung Cancer
6.3.3 Colorectal Cancer
6.3.4 Melanoma
6.3.5 Blood Cancer
6.3.6 Prostate Cancer
6.3.7 Ovarian Cancer
6.3.8 Stomach Cancer
6.3.9 Liver Cancer
6.3.10 Others
6.4 Market Attractiveness, By Disease Indication
6.5 Key Trends

7. Global Cancer Biomarkers Market Analysis and Forecast by Region
7.1 Key Findings
7.2 Introduction
7.2.1 Market Size (US$ Mn) Forecast, By Region
7.2.2 North America
7.2.3 Europe
7.2.4 Asia Pacific
7.2.5 Latin America
7.2.6 Middle East and Africa

8. North America Cancer Biomarkers Market Analysis and Forecast by Region
8.1 Key Findings
8.2 North America Cancer Biomarkers Market Forecast, by Test Type
8.3 North America Cancer Biomarkers Market Forecast, by Disease Indication
8.4 North America Cancer Biomarkers Market Forecast, by Country
8.4.1 U.S. Cancer Biomarkers Market Overview
8.4.2 Canada Cancer Biomarkers Market Overview
8.5 North America Market Attractiveness Analysis
8.6 Market Trends

9. Europe Cancer Biomarkers Market Analysis and Forecast by Region
9.1 Key Findings
9.2 Europe Cancer Biomarkers Market Forecast, by Test Type
9.3 Europe Cancer Biomarkers Market Forecast, by Disease Indication
9.4 Europe Cancer Biomarkers Market Forecast, by Country
9.4.1 U.K. Cancer Biomarkers Market Overview
9.4.2 Germany Cancer Biomarkers Market Overview
9.4.3 France Cancer Biomarkers Market Overview
9.4.4 Italy Cancer Biomarkers Market Overview
9.4.5 Spain Cancer Biomarkers Market Overview
9.4.6 Russia Cancer Biomarkers Market Overview
9.4.7 Rest of Europe Cancer Biomarkers Market Overview
9.5 Europe Market Attractiveness Analysis
9.6 Market Trends

10. Asia Pacific Cancer Biomarkers Market Analysis and Forecast by Region
10.1 Key Findings
10.2 Asia Pacific Cancer Biomarkers Market Forecast, by Test Type
10.3 Asia Pacific Cancer Biomarkers Market Forecast, by Disease Indication
10.4 Asia Pacific Cancer Biomarkers Market Forecast, by Country
10.4.1 India Cancer Biomarkers Market Overview
10.4.2 China Cancer Biomarkers Market Overview
10.4.3 Japan Cancer Biomarkers Market Overview
10.4.4 Australia & New Zealand Cancer Biomarkers Market Overview
10.4.5 Rest of APAC Cancer Biomarkers Market Overview
10.5 Asia Pacific Market Attractiveness Analysis
10.6 Market Trends

11. Latin America Cancer Biomarkers Market Analysis and Forecast by Region
11.1 Key Findings
11.2 Latin America Cancer Biomarkers Market Forecast, by Test Type
11.3 Latin America Cancer Biomarkers Market Forecast, by Disease Indication
11.4 Latin America Cancer Biomarkers Market Forecast, by Country
11.4.1 Brazil Cancer Biomarkers Market Overview
11.4.2 Mexico Cancer Biomarkers Market Overview
11.4.3 Rest of LATAM Cancer Biomarkers Market Overview
11.5 Latin America Market Attractiveness Analysis
11.6 Market Trends

12. Middle East and Africa Cancer Biomarkers Market Analysis and Forecast by Region
12.1 Key Findings
12.2 Middle East and Africa Cancer Biomarkers Market Forecast, by Test Type
12.3 Middle East and Africa Cancer Biomarkers Market Forecast, by Disease Indication
12.4 Middle East and Africa Cancer Biomarkers Market Forecast, by Country
12.4.1 South Africa Cancer Biomarkers Market Overview
12.4.2 GCC countries Cancer Biomarkers Market Overview
12.4.3 Rest of MEA Cancer Biomarkers Market Overview
12.5 Middle East and Africa Market Attractiveness Analysis
12.6 Market Trends

13. Competitive Landscape
13.1 Market Share Analysis, by Company
13.2 Competition Matrix
13.3 Company Profiles
13.3.1 Abbott Laboratories
13.3.1.1 Company Details
13.3.1.2 Business Overview
13.3.1.3 Financial Overview
13.3.1.4 Strategic Overview
13.3.1.5 SWOT Analysis
13.3.2 Merck & Co., Inc.
13.3.2.1 Company Details
13.3.2.2 Business Overview
13.3.2.3 Financial Overview
13.3.2.4 Strategic Overview
13.3.2.5 SWOT Analysis
13.3.3 Thermo Fisher Scientific Inc
13.3.3.1 Company Details
13.3.3.2 Business Overview
13.3.3.3 Financial Overview
13.3.3.4 Strategic Overview
13.3.3.5 SWOT Analysis
13.3.4 Illumina, Inc.
13.3.4.1 Company Details
13.3.4.2 Business Overview
13.3.4.3 Financial Overview
13.3.4.4 Strategic Overview
13.3.4.5 SWOT Analysis
13.3.5 bioMérieux SA
13.3.5.1 Company Details
13.3.5.2 Business Overview
13.3.5.3 Financial Overview
13.3.5.4 Strategic Overview
13.3.5.5 SWOT Analysis
13.3.6 QIAGEN
13.3.6.1 Company Details
13.3.6.2 Business Overview
13.3.6.3 Financial Overview
13.3.6.4 Strategic Overview
13.3.6.5 SWOT Analysis
13.3.7 Agilent Technologies, Inc.
13.3.7.1 Company Details
13.3.7.2 Business Overview
13.3.7.3 Financial Overview
13.3.7.4 Strategic Overview
13.3.7.5 SWOT Analysis
13.3.8 Hologic, Inc.
13.3.8.1 Company Details
13.3.8.2 Business Overview
13.3.8.3 Financial Overview
13.3.8.4 Strategic Overview
13.3.8.5 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Details
13.3.9.2 Business Overview
13.3.9.3 Financial Overview
13.3.9.4 Strategic Overview
13.3.9.5 SWOT Analysis
13.3.10 F. Hoffmann-La Roche Ltd.
13.3.10.1 Company Details
13.3.10.2 Business Overview
13.3.10.3 Financial Overview
13.3.10.4 Strategic Overview
13.3.10.5 SWOT Analysis
13.3.11 Genomic Health, Inc.
13.3.11.1 Company Details
13.3.11.2 Business Overview
13.3.11.3 Financial Overview
13.3.11.4 Strategic Overview
13.3.11.5 SWOT Analysis

Report Details

  • Report Code:34563
  • Category:Healthcare
  • No. of Pages:180
  • Format:PDF/PPT/Excel
  • Published:January 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers